Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Farley

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of the Advanced Practitioner in Oncology|February 3, 2021
Precautions for Patients Taking Aromatase InhibitorsMary Heery, Stephen Farley, Rhett Sparkman, et al.
Journal of Intensive Care Medicine|October 6, 2017
Prevalence and Overtesting of True Heparin-Induced Thrombocytopenia in a 591-Bed Tertiary Care, Teaching HospitalStephen Farley, Caitlyn Cummings, William Heuser, et al.
Surgical Neurology International|September 19, 2019
Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarateStephen Farley, Malcolm H Gottesman, Sharon Friedman-Urevich, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of the Advanced Practitioner in Oncology|February 3, 2021
Precautions for Patients Taking Aromatase InhibitorsMary Heery, Stephen Farley, Rhett Sparkman, et al.
Journal of Intensive Care Medicine|October 6, 2017
Prevalence and Overtesting of True Heparin-Induced Thrombocytopenia in a 591-Bed Tertiary Care, Teaching HospitalStephen Farley, Caitlyn Cummings, William Heuser, et al.
Surgical Neurology International|September 19, 2019
Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarateStephen Farley, Malcolm H Gottesman, Sharon Friedman-Urevich, et al.
Pageof 1